We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
926
DELISTED
Paramount Global Class B
PARA
| $3.31M | 0.01% |
135,773
-208,878
| -61% | -$6.37M |
|
927
Coherent
COHR
$64.3B
| $3.31M | 0.01% |
65,495
+46,287
| +241% | +$2.82M |
|
928
Covenant Logistics
CVLG
$847M
| $3.3M | 0.01% |
263,082
+3,468
| +1% | +$37.2K |
|
929
Diodes
DIOD
$4.75B
| $3.26M | 0.01% |
50,538
+1,458
| +3% | +$106K |
|
|
NESR
930
National Energy Services Reunited Corp
NESR
$3.63B
| $3.25M | 0.01% |
479,767
+285,555
| +147% | +$2.08M |
|
931
Meritage Homes
MTH
$4.81B
| $3.23M | 0.01% |
89,222
+15,416
| +21% | +$615K |
|
932
Watts Water Technologies
WTS
$12.8B
| $3.22M | 0.01% |
26,661
+10,787
| +68% | +$1.4M |
|
933
Morningstar
MORN
$7.33B
| $3.19M | 0.01% |
13,400
+432
| +3% | +$109K |
|
|
VRTV
934
DELISTED
VERITIV CORPORATION
VRTV
| $3.18M | 0.01% |
29,293
-1,704
| -5% | -$232K |
|
935
Sea Limited
SE
$80.5B
| $3.17M | 0.01% |
47,849
+30,423
| +175% | +$2.59M |
|
936
Central Pacific Financial
CPF
$996M
| $3.17M | 0.01% |
147,717
+79,519
| +117% | +$1.93M |
|
937
Metallus
MTUS
$900M
| $3.16M | 0.01% |
168,963
+78,904
| +88% | +$1.67M |
|
938
Tetra Tech
TTEK
$9.06B
| $3.15M | 0.01% |
119,110
+8,290
| +7% | +$227K |
|
939
Viasat
VSAT
$11.6B
| $3.14M | 0.01% |
103,851
+98,804
| +1,958% | +$3.82M |
|
940
US Bancorp
USB
$100B
| $3.12M | 0.01% |
69,464
-50,431
| -42% | -$2.52M |
|
941
United Natural Foods
UNFI
$2.86B
| $3.12M | 0.01% |
79,218
-15,502
| -16% | -$651K |
|
942
SunCoke Energy
SXC
$786M
| $3.12M | 0.01% |
457,412
+99,258
| +28% | +$800K |
|
943
TIM SA
TIMB
$8.62B
| $3.11M | 0.01% |
255,891
+82,119
| +47% | +$1.12M |
|
944
Enel Chile
ENIC
$6.18B
| $3.1M | 0.01% |
2,795,465
+415,298
| +17% | +$572K |
|
945
Neurocrine Biosciences
NBIX
$16.5B
| $3.1M | 0.01% |
32,007
-40,742
| -56% | -$3.76M |
|
946
Cboe Global Markets
CBOE
$29.5B
| $3.09M | 0.01% |
27,362
-52,765
| -66% | -$5.92M |
|
|
PR
947
Permian Resources
PR
$18B
| $3.08M | 0.01% |
515,029
+170,599
| +50% | +$1.36M |
|
|
NEX
948
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $3.08M | 0.01% |
323,343
+44,797
| +16% | +$470K |
|
|
AAWW
949
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $3.07M | 0.01% |
49,798
+15,752
| +46% | +$1.08M |
|
950
DaVita
DVA
$11.4B
| $3.06M | 0.01% |
38,579
+16,652
| +76% | +$1.69M |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.